Board of directors

Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on Bristol Myers Squibb's Leadership Team, who are responsible for the day-to-day operation of the company. Directors also act as advisors and counselors to our senior management.

Chris Boerner, PhD

Board Chair and Chief Executive Officer

Theodore R. Samuels

Lead Independent Director and Retired President of Capital Guardian Trust Company

Peter J. Arduini

President and Chief Executive Officer of GE Healthcare

Deepak L. Bhatt, MD, MPH 

Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine 

Julia A. Haller, MD

Ophthalmologist-in-Chief, Wills Eye Hospital

Michael R. McMullen

Former President and CEO, Agilent Technologies, Inc.

Manuel Hidalgo Medina, MD, PhD

Chief, Division of Hematology and Medical Oncology, Weill Cornell Medical College and Attending Physician, New York-Presbyterian Hospital

Paula A. Price

Former Executive Vice President and Chief Financial Officer, Macy’s, Inc.

Derica W. Rice

Former Executive Vice President, CVS Health and President, Pharmacy Benefits Business, CVS Caremark. Former Executive Vice President and Chief Financial Officer, Eli Lilly Company

Karen H. Vousden, PhD

Principal Group Leader of The Francis Crick Institute and Former Chief Scientist of Cancer Research UK

Phyllis R. Yale

Advisory Partner, Bain & Company